NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Frøya, 4 June 2025: Reference is made to the stock exchange release including the Q1 report and presentation published by Kaldvík AS (the "Company") on 28 May 2025 with details about the Company's refinancing package. As stated therein, the Company has received confirmatio ...

Today, on 4 June 2025, Kaldvik AS (the "Company") received a request from shareholders representing approximately 30% of the shares, to hold an extraordinary general meeting to consider a proposal to open an investigation relating to the agreement entered into between the Company, Heimstø AS and Osval ehf. to acquire 100% of the shares in Mossi ehf., Djupskel ehf., and 33.3% of the shares in Bulandstindur ehf., which was completed on 25 March 2025 and which the shareholders received additional information a ...

Press Release Paris – June 4, 2025 – EUROAPI, a European leader in the production of active pharmaceutical ingredients (API) and contract development and manufacturing organization (CDMO), is pleased to announce the appointment of Frédéric Robert to the newly created position of Chief Commercial Officer overseeing API Solutions and CDMO activities. He will join the company’s Executive Committee. This appointment is part of EUROAPI’s ongoing FOCUS-27 transformation plan and reinforces its position as a Eur ...

Press Release 74Software joins Euronext Tech Leaders, the initiative for high-growth and leading Tech companies Paris, June 4, 2025 – 74Software is delighted to announce its inclusion in the Euronext Tech Leaders segment, an initiative dedicated to supporting high-growth and leading tech companies. This significant recognition validates the continuous commitment of the company to excellence in entreprise software development and its contribution to digital innovation for nearly 25 years. Launched in June 20 ...

PRESS RELEASEParis, June 4, 2025 Information on the total number of voting rightsand shares forming the share capital(Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of the French Financial Markets Authority) DateIssued capitalPar valueTotal number of sharesTotal number of voting rightsTheoretical*Exercisable**May 30, 2025€ 244,633,504<td style="width:69.8px;;bor ...

Core Viewpoint - Alvotech intends to conduct a private placement of approximately 7.5 million Swedish Depository Receipts (SDRs) and ordinary shares to strengthen its shareholder base and fund R&D activities [2][4]. Group 1: Placement Details - The placement will be executed through an accelerated bookbuilding procedure, with pricing and total number of SDRs and ordinary shares to be determined during this process [3][6]. - The completion of the bookbuilding and pricing is expected before trading starts on Nasdaq Stockholm at 09:00 CEST on June 5, 2025 [3]. - The company may adjust the timing of the bookbuilding and has the discretion to shorten, extend, or suspend the placement [3]. Group 2: Use of Proceeds - Net proceeds from the placement are intended to accelerate Alvotech's R&D activities, particularly following the acquisition of Xbrane's R&D operations [4]. - The funds will also be used for general corporate purposes, allowing Alvotech to expand its pipeline and capitalize on growth opportunities [4]. Group 3: Shareholder and Management Commitments - The company and its executive management have agreed not to sell or transfer additional SDRs or ordinary shares for 180 days post-placement settlement, subject to certain conditions [7][8]. - Major shareholders have also committed to not dispose of their holdings for 90 days following the placement [10]. Group 4: Company Overview - Alvotech is a biotech company focused on developing and manufacturing biosimilar medicines, with two biosimilars already approved and a pipeline of nine candidates targeting various diseases [13]. - The company aims to be a global leader in the biosimilar market, leveraging strategic partnerships for market reach [13].

Group 1 - Siili Solutions Plc executed a share repurchase on June 4, 2025, buying back 1,100 shares at an average price of €6.36 per share, totaling €6,996 [1] - Following this transaction, Siili Solutions Plc now holds a total of 3,998 shares, including those repurchased on June 4, 2025 [1] - The share buybacks are conducted in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5 and the Commission Delegated Regulation (EU) 2016/1052 [1]

Group 1 - The Government Debt Management will auction Treasury bills with specific ISIN numbers and maturity dates on June 6, 2025 [1] - The Treasury bill RIKV 25 0917 matures on September 17, 2025, while RIKV 25 1217 matures on December 17, 2025 [1] - Payments for the Treasury bills must be received by the Central Bank before 14:00 on the settlement date, with electronic delivery on the same day [1] Group 2 - The Treasury bill RIKV 25 0917 is registered electronically at Verðbréfamiðstöð Íslands hf. central securities depository (VBM) [2] - The Treasury bill RIKV 25 1217 will be registered at Nasdaq CSD [2] - Additional information can be obtained from the Government Debt Management website regarding the General Terms of Icelandic Treasury bills and auction [2]

Group 1 - The issuance of new shares in Kaldvik AS was announced on 22 April 2025 [1] - Heimstø AS and Ósval ehf., close associates to a primary insider of Kaldvik AS, have completed transactions in the Company's shares [1] - The information is subject to disclosure requirements under the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12 [1]

NASHVILLE, Tenn., June 04, 2025 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”) announced today that its subsidiaries, RHP Hotel Properties, LP (the “Operating Partnership”) and RHP Finance Corporation (together with the Operating Partnership, the “Issuers”), completed the previously announced private placement of $625 million aggregate principal amount of 6.500% senior notes due 2033 (the “Notes”). The Notes are senior unsecured obligations of the Issuers and are guarante ...